Results

Total Results: 3,024 records

Showing results for "diseases".

321. The Effect of Protein Intake on Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol.pdf
     May 01, 2023 - for sodium and potassium.4,5 Bone disease, kidney disease, and sarcopenia are thought to be some of … Element Inclusion Exclusion Population KQ1 Participants who are healthy and/or have chronic diseases … animal studies, in-vitro models) Population KQ2&3 Participants who are healthy and/or have chronic diseases … ti,ab. 351405 2 "Bone and Bones"/ or Bone Density/ or bone diseases/ or bone diseases, metabolic/ or … bone resorption or fracture* or osteoporosis or osteopenia).ti,ab. 526554 3 kidney calculi/ or Kidney Diseases

322. Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-effectiveness
     February 08, 2011 - Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease … Effectiveness of Medical Therapy, Endovascular Therapy, and Surgery for Peripheral Arterial Disease

323. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia
     January 14, 2013 - Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future … Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease

324. My nomination is about comparing outcomes of different glaucoma treatments, particularly canaloplasty to trabeculectomy and to medical therapy alone. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/my-nomination-is-about-comparing-outcomes-of-different-glaucoma-treatments-particularly-canaloplasty-to-trabeculectomy-and-to-medical-therapy-alone
     November 23, 2008 - (you may select more than one category if appropriate)   My question relates to a very common disease … or problem   People with this disease or problem have considerable health or financial hardships   There … or condition:   Screening or diagnosis/identification for a particular disease, or risk assessment for … a disease   Risks or harms that can come from a disease identification tool or test   Diagnostic tests … and tools   Diagnosis of co-occurring diseases   Intervention (such as a drug treatment, therapy, device

325. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/uterine-fibroids-2010/research
     March 10, 2011 - Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease Research … research agenda and protocol to study the clinical and/or comparative effectiveness of uterine fibroid disease … Little information is available on the long-term effects of procedural or medical therapy on fibroid disease … and state and federal partners all relevant and interested in advancing comparative uterine fibroid disease … This meeting produced a final prioritized research agenda for uterine fibroid disease management and

326. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
     October 01, 2009 - Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … cannot be determined at this time. 1 The JMIC-B (Japan Multicenter Investigation for Cardiovascular Diseases-B

327. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
     July 01, 2016 - history of the disease. … by the AGA9 including the introduction of biologics into the treatment algorithm for inflammatory diseases … history of the disease. … by the AGA9 including the introduction of biologics into the treatment algorithm for inflammatory diseases … Review article: Crohn's disease: monitoring disease activity.

328. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
     September 01, 2010 - ’s disease are at risk for growth retardation in the absence of adequately treated disease. … Our search strategy for MEDLINE is: (“Crohn Disease”[mh] OR “Crohn’s Disease”[tiab] OR “Crohn Disease … [tiab] OR colitis[tiab])) OR “inflammatory bowel diseases”[mh] OR “inflammatory bowel disease”[tiab] … OR “inflammatory bowel diseases”[tiab] OR IBD[tiab]) AND (“Aminosalicylic acids”[mh] OR “Anti- inflammatory … Disease activity courses in a regional cohort of Crohn's disease patients.

329. Ahrq Community Forum Webinar Branson (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_branson.pdf
     October 13, 2011 - SRA. 4 Characteristics of Patient Representatives • Have personal experience with the disease … • Are knowledgeable about treatment options and/or the science of the disease • Are able to be … groups may offer an opportunity to identify patients who might be underrepresented (such as for rare diseases … Advocacy experience – Ability to represent other patients/survivors – Knowledge and skills related to disease … area – Alternate disease experience – Work experience – Education • Interview representatives

330. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/heart-disease-ace-inhibitor-arb-future
     November 05, 2010 - Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease … Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease

331. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR " … [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR " … '/exp OR 'ischemic heart disease'/exp OR cad OR 'coronary artery disease' OR 'coronary disease' OR ' … , peripheral vascular disease, diabetes, chronic kidney disease, or congestive heart failure. … ICD-9 (International Classification of Diseases, Ninth Revision) and CPT (Current Procedural Terminology

332. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/thrombosis-plays-a-a-key-role-in-the-pathophysiology-of-myocardial-infarction-a-leading-cause-of-morbidity-and-mortality-there-have-been-a-number-of-devices-proposed-for-mechanical-thrombectomy-in-patients-with-in-the-setting
     June 19, 2008 - (you may select more than one category if appropriate)   My question relates to a very common disease … or problem   People with this disease or problem have considerable health or financial hardships   There … or condition:   Screening or diagnosis/identification for a particular disease, or risk assessment for … a disease   Risks or harms that can come from a disease identification tool or test   Diagnostic tests … and tools   Diagnosis of co-occurring diseases   Intervention (such as a drug treatment, therapy, device

333. Cervical Degenerative Disease Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease

334. Cervical Degenerative Disease Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cervical-degenerative-disease/protocol

335. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0504_02-17-2012.pdf
     January 01, 2012 - Diuretics for Meniere's disease or syndrome. … /surgery-for-menieres-disease http://summaries.cochrane.org/CD005395/surgery-for-menieres-disease http … Management of Ménière’s disease symptoms 4. … or syndrome; Intratympanic steroids for Ménière’s disease or syndrome; Surgery for Ménière’s disease … ; Betahistine for Ménière's disease or syndrome; and Diuretics for Ménière's disease or syndrome; and

336. Medication Therapy Management | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/medication-therapy-management/research-protocol
     July 24, 2013 - CMS required that MTM programs target Medicare Part D enrollees, who have multiple chronic diseases, … obstructive pulmonary disease), bone disease (e.g., osteoporosis, osteoarthritis, rheumatoid arthritis … ), and mental health diseases. … Patient-centered outcomes, such as disease-specific morbidity, disease-specific or all-cause mortality … symptoms, reduced number of disease-specific acute exacerbations or events) Disease-specific or all-cause

337. Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/gerd-2005
     December 13, 2005 - Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease … Archived Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease

338. Summary Variables in Observational Research:Propensity Scores and Disease Risk Scores | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/observational-research-scores
     May 15, 2012 - Summary Variables in Observational Research:Propensity Scores and Disease Risk Scores Timeline … Research Report Summary Variables in Observational Research: Propensity Scores and Disease

339. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/copd-management
     December 04, 2009 - Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline Timeline … 04, 2009 Research Report Mortality Risk in Chronic Obstructive Pulmonary Disease

340. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/uterine-fibroids-2010
     March 10, 2011 - Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease … Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease